Anti-CXCR3/GPR9/CD183 Antibody is a potent monoclonal antibody targeting the chemokine receptor CXCR3, acting by competitively blocking the binding of pro-inflammatory chemokines (such as CXCL10) to the receptor's extracellular domain. The compound is an essential tool for investigating effector T cell recruitment, the pathogenesis of autoimmune diseases, and tumor immune microenvironment remodeling, aiming to inhibit excessive inflammatory cell infiltration by intervening in the CXCR3-mediated signaling axis.